New drug MTX-439 enters first human safety tests
Knowledge-focused
Not yet recruiting
This early-stage study tests the safety and how the body handles a new drug called MTX-439. It involves 88 healthy adults and people with diabetic kidney disease. The main goal is to check for side effects and measure drug levels in the blood, not to treat the disease.
Phase: PHASE1 • Sponsor: Mediar Therapeutics • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC